New rehab combo aims to ease MS fatigue and boost brain function

NCT ID NCT07666958

Not yet recruiting Symptom relief Sponsor: Charles University, Czech Republic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 12-week program combining individual physiotherapy, group movement-awareness sessions, and group psychotherapy can improve physical function, reduce fatigue, and enhance quality of life in 45 adults with multiple sclerosis. Each participant serves as their own control, with assessments before and after the program, including brain MRI scans to look for changes in brain connections. The goal is to see if this non-drug approach can help people with MS stay active in daily life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: physiotherapy, movement awareness sessions, and psychotherapy
What this could lead to: If it works, this could point toward a non-drug rehabilitation program that helps people with MS move better, feel less tired, and enjoy a higher quality of life.
What could go wrong: This is a small early study with only 45 participants and no control group, so results may not apply to everyone. The program is time-intensive, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fatigue multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS

Contacts and locations

Locations

University Hospital Kralovske Vinohrady, Department od Rehabilitation Medicine

Prague, Czech Republic, 10034, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.